eRx market predicted to reach $794M by 2017

The global electronic prescribing (eRX) systems market is expected to hit $794 million by 2017, according to a report from market research firm MarketsandMarkets. The report analyzed and studied the market’s major drivers, restraints and opportunities in North America, Europe, Asia-Pacific and elsewhere throughout the world.

In the U.S., the widespread adoption is driven by Meaningful Use under the EHR incentive program, which requires eRX. Also, providers worldwide turn to eRX to cut costs, improve quality and efficiency, promote appropriate drug usage, provide information to providers and dispensers about formulary-based drug coverage, and to speed up the process of renewing medications, according to the report.

As healthcare systems in developing countries do not have integrated and well-connected networks, they lack the ability to use important features of eRX systems. As such, growth is restrained in these markets.

Overall, the market is driven by a few established companies and smaller companies striving to gain maximum market share. The predominant strategy followed by all players of this market is launching new products with usability in mind. Major players, including Surescripts, Cerner Corp., Allscripts, Athenahealth, iMedX, DrFirst, Emdeon, eClinicalWorks, Practice Fusion and Bizmatics, mainly focus on the development of eRx solutions as standalone or as integrated module of EHRs and practice management.

Access more about the report here.